Alternative tumor markers in the diagnosis of ovarian cancer.

Karakaya, Burcu Kisa; Baser, Eralp; Bildaci, Berk; Cömert, Esra Çabuk; Bayraktar, Nilufer; Dursun, Polat; Kusçu, Esra; Ayhan, Ali

Karakaya, Burcu Kisa; Baser, Eralp; Bildaci, Berk; Cömert, Esra Çabuk; Bayraktar, Nilufer; Dursun, Polat; Kusçu, Esra; Ayhan, Ali.

Affiliation

Baser E; eralpbaser@gmail.com.

Ginekol Pol ; 87(8): 565-769, 2016.

Article in En | MEDLINE | ID: mdl-27629130

Subject(s)

Biomarkers, Tumor/analysis; Ovarian Neoplasms/diagnosis; Adult; Aged; Aged, 80 and over; Biomarkers, Tumor/blood; Biomarkers, Tumor/urine; CA-125 Antigen/analysis; CA-125 Antigen/blood; Cross-Sectional Studies; Diagnosis, Differential; Female; Humans; Middle Aged; Proteins/analysis; Proto-Oncogene Proteins c-bcl-2/analysis; Proto-Oncogene Proteins c-bcl-2/urine; Saliva/chemistry; WAP Four-Disulfide Core Domain Protein 2

Key words

CA125; HE4; adnexal mass; bcl2; ovarian cancer; tumor marker

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Ovarian Neoplasms / Biomarkers, Tumor Type of study: Diagnostic_studies / Observational_studies / Prevalence_studies / Risk_factors_studies Limits: Adult / Aged / Aged80 / Female / Humans / Middle aged Language: En Journal: Ginekol Pol Year: 2016 Type: Article

Fulltext

XML

PubMed Links

Search on Google